Home Cart 0 Sign in  
X

[ CAS No. 4363-93-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4363-93-3
Chemical Structure| 4363-93-3
Chemical Structure| 4363-93-3
Structure of 4363-93-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4363-93-3 ]

Related Doc. of [ 4363-93-3 ]

Alternatived Products of [ 4363-93-3 ]

Product Details of [ 4363-93-3 ]

CAS No. :4363-93-3 MDL No. :MFCD00006781
Formula : C10H7NO Boiling Point : -
Linear Structure Formula :- InChI Key :MGCGJBXTNWUHQE-UHFFFAOYSA-N
M.W : 157.17 Pubchem ID :78072
Synonyms :

Calculated chemistry of [ 4363-93-3 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.13
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.97 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.5
Log Po/w (XLOGP3) : 0.4
Log Po/w (WLOGP) : 2.05
Log Po/w (MLOGP) : 1.14
Log Po/w (SILICOS-IT) : 2.62
Consensus Log Po/w : 1.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.62
Solubility : 3.8 mg/ml ; 0.0241 mol/l
Class : Very soluble
Log S (Ali) : -0.6
Solubility : 39.9 mg/ml ; 0.254 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.63
Solubility : 0.0364 mg/ml ; 0.000232 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 4363-93-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4363-93-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4363-93-3 ]
  • Downstream synthetic route of [ 4363-93-3 ]

[ 4363-93-3 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 491-35-0 ]
  • [ 4363-93-3 ]
YieldReaction ConditionsOperation in experiment
73% With selenium(IV) oxide In toluene for 24 h; Inert atmosphere; Reflux General procedure: A solution of 5.0 g (35 mmol) of 4-methylquinoline (19) and 5.0 g (45 mmol) of SeO2 in toluene under argon was heated to reflux for 24 h. The reaction mixture was diluted with dichloromethane, washed with brine, dried (MgSO4), concentrated, and column chromatographed on silica gel using a mixture of hexanes and ethyl acetate (4:1) as eluant to give 4.0 g (73percent yield) of compound 14A,12 as a solid. 1H NMR δ 10.54 (s, 1 H), 9.22 (d, J = 4.3 Hz, 1 H), 9.04 (d, J = 8.6 Hz, 1 H), 8.24 (d, J = 8.2 Hz, 1 H), 7.84 (t, J = 7.6 Hz, 1 H), 7.81 (d, J = 4.3 Hz, 1 H), 7.76 (t, J = 8.0 Hz, 1 H); 13C NMR δ 193.1, 150.7, 149.5, 137.0, 130.4, 130.3, 129.6, 126.0, 124.7, 124.1. MS (electrospray ionization) m/z 158.0 (100percent) (M+H+), 130.2.
Reference: [1] Gazzetta Chimica Italiana, 1987, vol. 117, # 2, p. 135 - 136
[2] Chinese Journal of Chemistry, 2016, vol. 34, # 5, p. 519 - 523
[3] Heterocycles, 2003, vol. 60, # 4, p. 953 - 957
[4] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, # 9, p. 2179 - 2186
[5] Journal of Heterocyclic Chemistry, 1988, vol. 25, p. 819 - 821
[6] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 10, p. 3480 - 3484
[7] Chemical Communications, 2015, vol. 51, # 61, p. 12258 - 12261
[8] Chemistry of Natural Compounds, 2006, vol. 42, # 4, p. 459 - 461
[9] Chemistry Letters, 1991, p. 1271 - 1274
[10] Advanced Synthesis and Catalysis, 2016, vol. 358, # 2, p. 178 - 182
[11] Chemische Berichte, 1953, vol. 86, p. 572
[12] Chemische Berichte, 1954, vol. 87, p. 1179,1183
[13] Chemische Berichte, 1954, vol. 87, p. 1179,1183
[14] Journal of the American Chemical Society, 1937, vol. 59, p. 524
[15] Journal of the American Chemical Society, 1947, vol. 69, p. 1219
[16] Journal of the American Chemical Society, 1941, vol. 63, p. 2654
[17] Liebigs Annalen der Chemie, 1988, p. 455 - 464
[18] Pakistan Journal of Scientific and Industrial Research, 1993, vol. 36, # 9, p. 357 - 359
[19] Gazzetta Chimica Italiana, 1987, vol. 117, # 2, p. 135 - 136
[20] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 14, p. 3771 - 3774
[21] Tetrahedron, 2009, vol. 65, # 12, p. 2512 - 2517
[22] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 3, p. 1201 - 1212
  • 2
  • [ 5450-80-6 ]
  • [ 4363-93-3 ]
Reference: [1] Acta Chimica Academiae Scientiarum Hungaricae, 1981, vol. 107, p. 315 - 320
  • 3
  • [ 611-35-8 ]
  • [ 20461-86-3 ]
  • [ 4363-93-3 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 6, p. 1500 - 1505[2] Angew. Chem., 2017, vol. 129, # 6, p. 1522 - 1527,6
  • 4
  • [ 6281-32-9 ]
  • [ 4363-93-3 ]
Reference: [1] RSC Advances, 2014, vol. 4, # 76, p. 40561 - 40568
  • 5
  • [ 491-35-0 ]
  • [ 4363-93-3 ]
  • [ 486-74-8 ]
Reference: [1] Synthetic Communications, 1996, vol. 26, # 9, p. 1681 - 1684
  • 6
  • [ 491-35-0 ]
  • [ 4363-93-3 ]
  • [ 5428-66-0 ]
Reference: [1] Journal of the American Chemical Society, 1941, vol. 63, p. 2654
[2] Chemische Berichte, 1954, vol. 87, p. 1179,1183
  • 7
  • [ 5632-16-6 ]
  • [ 4363-93-3 ]
Reference: [1] Chemical and pharmaceutical bulletin, 1994, vol. 42, # 3, p. 512 - 520
  • 8
  • [ 87-51-4 ]
  • [ 4363-93-3 ]
Reference: [1] Heterocycles, 1983, vol. 20, # 3, p. 421 - 424
[2] Tetrahedron, 1985, vol. 41, # 11, p. 2109 - 2114
  • 9
  • [ 1912-33-0 ]
  • [ 4363-93-3 ]
Reference: [1] Tetrahedron, 1985, vol. 41, # 11, p. 2109 - 2114
  • 10
  • [ 2591-98-2 ]
  • [ 4363-93-3 ]
Reference: [1] Tetrahedron, 1985, vol. 41, # 11, p. 2109 - 2114
[2] Heterocycles, 1983, vol. 20, # 3, p. 421 - 424
  • 11
  • [ 110-88-3 ]
  • [ 91-22-5 ]
  • [ 5470-96-2 ]
  • [ 4363-93-3 ]
Reference: [1] Journal of Organic Chemistry, 1986, vol. 51, # 4, p. 536 - 537
[2] Journal of Organic Chemistry, 1986, vol. 51, # 4, p. 536 - 537
  • 12
  • [ 123-91-1 ]
  • [ 491-35-0 ]
  • [ 7446-08-4 ]
  • [ 7732-18-5 ]
  • [ 4363-93-3 ]
  • [ 5428-66-0 ]
Reference: [1] Journal of the American Chemical Society, 1941, vol. 63, p. 2654
  • 13
  • [ 491-35-0 ]
  • [ 7446-08-4 ]
  • [ 108-88-3 ]
  • [ 4363-93-3 ]
  • [ 5428-66-0 ]
Reference: [1] Chemische Berichte, 1954, vol. 87, p. 1179,1183
  • 14
  • [ 4363-93-3 ]
  • [ 2973-27-5 ]
YieldReaction ConditionsOperation in experiment
94% With ammonium acetate; phenyltrimethylammonium tribromide In acetonitrile at 20℃; for 17 h; General procedure: to a solution of 2-pyridinecarbaldehyde 1 (54 mg, 0.5 mmol) and ammonium acetate (385mg, 5.0 mmol) in MeCN )6ml), was added trimethylphenylammonium tribromide (376 mg, 1.0 mmol) at room temperature. after stirring for 21 h at rt, the reaction mixture was treated with 0.5 M aq Na2S2O3(10 ml), 1.0 M NaHCO3 )15 ml) and extracted with EtOAc (60 mL). The organic layer was washed with 0.5 M Na2S2O3 and successively washed with saturated aq.NaCl, and dried over MgSO4.
50.5%
Stage #1: With sodium bromate; ammonia In water at 90℃; for 2 h;
Stage #2: With sodium hydrogencarbonate In water; ethyl acetate
Example 4:
Production of 4-quinolinecarbonitrile
Into a 15 ml, test tube-shaped reactor equipped with a magnetic stirrer and a reflux condenser were added 0.71 g (4.5 mmol) of 4-quinolinecarboaldehyde, 0.27 g (1.8 mmol) of sodium bromate, 0.6 g (10 mmol) of acetic acid, 0.35 g (5 mmol) of 25percent aqueous ammonia and 1 ml of water, followed by stirring at 90°C for 2 hours.
The reaction mixture contained, as a component, 97.4percent (in terms of areal ratio of gas chromatography) of 4-quinolinecarbonitrile.
To the reaction mixture were added 30 ml of a saturated aqueous sodium bicarbonate solution and 30 ml of ethyl acetate.
The mixture was subjected to phase separation.
Then, there were conducted washing with a saturated aqueous sodium chloride solution, drying over anhydrous sodium sulfate, and distillation under reduced pressure for ethyl acetate removal.
The residue was purified by silica gel column chromatography (ethyl acetate/n-hexane = 1:1 v/v) to obtain 0.35 g (yield: 50.5percent) of white crystals.
Gas mass chromatography was conducted to confirm a molecular ion peak [M+] of 154.
Reference: [1] Heterocycles, 2016, vol. 92, # 10, p. 1796 - 1802
[2] Patent: EP1555257, 2005, A1, . Location in patent: Page/Page column 24
  • 15
  • [ 4363-93-3 ]
  • [ 90965-06-3 ]
  • [ 62484-52-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8765 - 8780
  • 16
  • [ 4363-93-3 ]
  • [ 728033-97-4 ]
  • [ 728033-96-3 ]
Reference: [1] Patent: US2004/186124, 2004, A1, . Location in patent: Page/Page column 12
[2] Patent: US2005/154014, 2005, A1,
  • 17
  • [ 4363-93-3 ]
  • [ 1062368-24-4 ]
Reference: [1] Patent: WO2009/114180, 2009, A1,
Same Skeleton Products
Historical Records